AD Ports Logistics (ADPL), a key provider of integrated end-to-end business solutions and a subsidiary of AD Ports Group’s Logistics Cluster, has announced the addition of a new distribution business line that will see the company secure exclusive distribution rights for a range of healthcare products.
Read more:
AD Ports, KMTF ink agreement to provide offshore and shipping services
AD Ports’ SAFEEN Feeders launches new UAE-Red Sea service
New offering
The business will target the GCC’s booming healthcare and life sciences sector, whose market size is projected to increase at a compound annual growth rate (CAGR) of 4.9% to $99.6 billion (AED365.7 billion) in 2023 from $86.2 billion (AED316.6 billion) in 2020.
As a distributor licensed by the UAE Ministry of Health and Prevention (MOHAP) and Abu Dhabi Department of Health, ADPL will procure high-in-demand healthcare products, including pharmaceuticals, cosmetics, medical devices, baby products, and nutraceuticals from leading manufacturers seeking to access the UAE and GCC markets, and manage end-to-end product storage and deliveries to hospitals, clinics, pharmacies, wholesalers, and retailers.
“Our healthcare and life sciences team has a proven track record of successfully managing logistics for all types of healthcare products, and we look forward to our next phase of growth as the new distributor of choice serving the local and regional marketplace,” remarked Farook Al Zeer, Chairman, Logistics Cluster, AD Ports Group, said.
Capabilities and services
With multimodal connectivity facilitating access to global markets via the UAE’s main ports, including Khalifa Port, Zayed Port, and Jebel Ali Port, as well as two international airports, the E311 cargo corridor and the future Etihad Rail link; ADPL’s fully-integrated one-stop supply chain offering is set to boost the availability of healthcare products across the region.
The offering combines 24/7 3PL and 4PL logistics services, 31,000 square metres of state-of-the-art storage capacity, and cold-chain management, supported by a fleet of over 400 vehicles.
Tailoring to customers’ needs, the new business line will provide a range of value-added services including, serialisation, aggregation, bundling, shrink-wrapping, kitting, home deliveries of medications, and many others.
